Journals / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 4

Disease-Modifying Antirheumatic Drugs and Remote Ischemic Postconditioning Ameliorate for Myocardial Injury in Rats Under Cerebral Stroke

Pages
429–434
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

They acted by mobilizing the endogenous adaptive mechanisms in the myocardium and inhibited oxidative stress by increasing the activity of antioxidant enzymes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Currently, there is uncertainty about the increased risk of myocardial infarction following ischemic stroke or transient ischemic attack and the method of risk management after the stroke.
📊
Key Findings & Data:Materials and Methods: Global cerebral ischemia was induced by occluding the bilateral common carotid arteries for 20 minutes and subsequently reperfusing them.
💡
Conclusion & Impact:They acted by mobilizing the endogenous adaptive mechanisms in the myocardium and inhibited oxidative stress by increasing the activity of antioxidant enzymes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objective: Currently, there is uncertainty about the increased risk of myocardial infarction following ischemic stroke or transient ischemic attack and the method of risk management after the stroke. In this experimental study, we aimed to evaluate myocardial injury after inducing global cerebral ischemia in rats and assess their responses to the treatments with diseasemodifying antirheumatic drugs (DMARDs) and ischemic postconditioning (PC). Materials and Methods: Global cerebral ischemia was induced by occluding the bilateral common carotid arteries for 20 minutes and subsequently reperfusing them. Thirty-two Wistar rats were divided into 4 treatment groups (n=8 for each group). Group I received 7 mg/kg/day infliximab immediately and at 6 hours after the stroke and group II received 10 mg/ kg/day leflunomide immediately and at 6 hours after the stroke. In group III, the skeletal muscle in the limbs was clamped for 180 minutes immediately after the stroke and was reperfused for 120 minutes. Group IV was sham-operated and received saline immediately and at 6 hours after the stroke. Myocardium tissue samples were collected for histopathologic assays and to create hypoxia-induced tissue oxidative markers. Results: We found that apoptosis and nucleus loss in the myocardium were significantly decreased after the administration of infliximab, leflunomide, and remote ischemic PC. Necrosis in the myocardium and cardiac malondialdehyde (MDA) level were also significantly decreased after treatment with remote skeletal muscle PC. Conclusion: Our findings demonstrated that remote ischemic PC and DMARDs were protective against cerebral ischemia/ reperfusion injury. They acted by mobilizing the endogenous adaptive mechanisms in the myocardium and inhibited oxidative stress by increasing the activity of antioxidant enzymes.

🔖

Cite This Article

AYKAN, D. A., SEYİTHANOĞLU, M., KAZANCI, Ü. (2019). Disease-Modifying Antirheumatic Drugs and Remote Ischemic Postconditioning Ameliorate for Myocardial Injury in Rats Under Cerebral Stroke. Erciyes Medical Journal, Cilt: 41 - Sayı: 4, 429–434. https://ajindex.com/articles/216834

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Boulanger M, Béjot Y, Rothwell PM, Touzé E. Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta- Analysis. J Am Heart Assoc 2018; 7(2): e007267
  2. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2014; 45(7): 2160–236
  3. Arango-Dávila CA, Vera A, Londoño AC, Echeverri AF, Cañas F, Cardozo CF, et al. Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats. Int J Neurosci 2015; 125(12): 936–40. 4. van Sijl AM, Peters MJ, Knol DL, de Vet RH, Sattar N, Dijkmans BA, et al. The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis. Semin Arthritis Rheum 2011; 41(3): 393–400
  4. Jagpal A, Navarro-Millán I. Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment. BMC Rheumatol 2018; 2: 10
  5. Low AS, Symmons DP, Lunt M, Mercer LK, Gale CP, Watson KD, et al; British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR-RA), the BSRBR Control Centre Consortium. Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. Ann Rheum Dis 2017; 76(4): 654–60
  6. Day AL, Singh JA. Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease- Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? Drugs Aging 2019; 36(6): 493–510
  7. Keep RF, Wang MM, Xiang J, Hua Y, Xi G. Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res 2010; 1(1): 4–18
  8. Sun Y, Zhang T, Zhang Y, Li J, Jin L, Sun Y, et al. Ischemic Postconditioning Alleviates Cerebral Ischemia-Reperfusion Injury Through Activating Autophagy During Early Reperfusion in Rats. Neurochem Res 2018; 43(9): 1826–40
  9. Selçuk EB, Sungu M, Parlakpinar H, Ermiş N, Taslıdere E, Vardı N, et al. Evaluation of the cardiovascular effects of vare